Neonatal hypertension is an increasingly recognised challenge in modern neonatal care, closely linked to improved survival rates among premature and critically ill infants. Advances in neonatal ...

A new guideline to diagnose and treat hypertension is aimed at helping primary care clinicians, including family physicians, nurses, nurse practitioners, and pharmacists, manage the disease. The new ...

In the last several years, there have been numerous advancements in the field of pulmonary hypertension as a whole, but there have been few changes in the management of children with pulmonary ...

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The treatment, called baxdrostat, has been hailed as the most ...

Digital health interventions can help reduce disparities in hypertension control for racial/ethnic minorities and disadvantaged populations. Tailored approaches that are culturally-sensitive and ...

In a recent study published in JAMA Network Open, researchers compared blood pressure (BP) self-monitoring along with self-titration of antihypertensive medication to usual care for patients with ...

Vivek Bhalla, MD, Stanford, calls for greater awareness and implementation of existing screening guidelines to help identify patients who may benefit from more targeted, disease-specific interventions ...

Hypertension — or high blood pressure — affects about 120 million adults in the U.S. and can lead to heart disease, stroke and chronic kidney disease. There is also a higher prevalence of hypertension ...

High blood pressure often lurks without symptoms, earning its reputation as the “silent killer.” With nearly half of American adults affected by this condition, understanding the different stages of ...

Three combination therapies for hypertension are equally effective in reducing blood pressure, according to a new global study conducted in India, where this significant health burden affects nearly ...

Hypertension, the most prevalent risk factor for cardiovascular disease, affects 1.39 billion adults worldwide and has a 46% uncontrolled rate. That poses a substantial burden for hospitals and health ...